"No swift action" on US CBD regulation after FDA comments, warns analyst

Home › "No swift action" on US CBD regulation after FDA comments, warns analyst

CBD beverage producers in the US may have to wait for clarity on regulation as authorities look set to miss a February deadline, an analyst has said.

29.01	Millions to get 150 off energy bills for further five years
29.01	Millions to get 150 off energy bills for further five years
29.01	Apple reports best-ever iPhone sales as Mac dips
29.01	Venezuelan MPs approve bill to open up oil sector to private firms
29.01	Planning bids for new homes rise in England but building remains low, data suggests
29.01	H5N1 Risk to Swine Research Program seeks 2nd round of proposals
29.01	Pig breeder Muyuan Foods seeks up to $1.4 Billion in Hong Kong listing
29.01	duBreton responds to Canada's approval of the PRRS-resistant pig
More »

je.st